Skip to content
Home > Resources

Videos and Documents

Videos

View our videos on studies that include
Decipher testing

Go to Videos page

Test Reports

Download the test report samples for the Decipher Prostate and Decipher Bladder Genomic Classifiers

Go to Test Report Page

Requisitions & Shipping Instructions

Download the requisition and shipping Instructions for the Decipher Prostate and Decipher Bladder Genomic Classifiers

Go to Requisitions Page

Decipher Prostate Brochures for Patients and Physicians

Download the patient and physician brochures for the Decipher Prostate Genomic Classifier in English and Spanish

Go to Brochures Page

Local Coverage Determination for Decipher Prostate

View our Local Coverage Determination for Decipher Prostate

Go to LCD for Decipher Prostate

Local Coverage Determination for Decipher Bladder

View our Local Coverage Determination for Decipher Bladder

Go to LCD for Decipher Bladder

Publications

We are dedicated to the continued pursuit of evidence. The Decipher Prostate Genomic Classifier has been validated in over 70 studies of more than 100,000 patients as a highly accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.

Filters

December 2022

Decipher Bladder Genomic Classifier

CLINICAL CANCER RESEARCH

Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial

Basile G, et al

March 2023

Decipher Prostate RP

THE BRITISH JOURNAL OF RADIOLOGY

The combination of prostate MRI PI-RADS scoring system and a genomic classifier is associated with pelvic lymph node metastasis at the time of radical prostatectomy

Benedir T, et al

April 2023

Decipher Prostate Biopsy

European Urology Oncology

Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography

Smith CP, et al

July 2023

Reviews including Decipher

THE INTERNATIONAL JOURNAL OF RADIATION

Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus

Spohn S, et al

August 2023

Decipher GRID

JCO PRECISION ONCOLOGY

Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial

Bitting RL, et al

References

  1. Xie W, et al. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer. J Clin Oncol. 2017.
  2. Gharzai LA, et al. Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis. Lancet Oncol. 2021.